Page 2 - Memory Centre News Today

Rencontrez les membres de léquipe du Pôle Santé Social

Alzheimer's disease, one of the most common neurodegenerative diseases, leads to progressive loss of memory and autonomy.

Alzheimer’s disease, one of the most common neurodegenerative diseases, leads to progressive loss of memory and autonomy. It is characterised by the accumulation of neurotoxic proteins in the brain, namely amyloid plaques and tau tangles. Due to the silent development of pathology over decades, very early diagnosis is of utmost importance to be able to take action as early as possible in the disease process. A team from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG)...

After months of anticipation, US Food and Drug administration has finally granted traditional approval to lecemab, a drug that's been shown to significantly slow the progression of Alzheimer's.

(CTN NEWS) - The Food and Drug Administration (FDA) has endorsed the intravenous (IV) drug Leqembi for patients with mild dementia and early Alzheimer's

MEMBERS of a healthcare team have been celebrating the opening of a newly refurbished centre.

An international research team led by the UNIGE and the HUG has shown that amyloid and tau blood-based biomarkers are highly correlated with the corresponding biomarkers used so far for the diagnosis of Alzheimer’s disease. Furthermore, the blood-bas

The study showed that the highest levels of tau, a protein involved in Alzheimer's, were only observed in hormone therapy users who reported a long delay between age at menopause onset and their initiation of the therapy

An international research team led by the HUG and the UNIGE has shown that amyloid and tau blood-based biomarkers are highly correlated with the corresponding biomarkers used so far for the diagnosis of Alzheimer's disease.

Women's History Month may only really be celebrated in the US, but there are lots of events in Europe this March highlighting women's achievements.